Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients

Toxicology Letters

Volumn 232, Issue 1, 2015, Pages 221-225

  Morita, Kazunori ^a   Miyazaki, Hiroko ^a   Saruwatari, Junji ^a   Oniki, Kentaro ^a   Kumagae, Naoki ^a   Tanaka, Takahiro ^a   Kajiwara, Ayami ^a   Otake, Koji ^b   Ogata, Yasuhiro ^b   Arima, Yuichiro ^c   Hokimoto, Seiji ^c   Ogawa, Hisao ^c   Nakagawa, Kazuko ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Aldehyde dehydrogenase 2; Myocardial infarction; Smoking; Stable angina; Triglycerides

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; CREATINE KINASE; ALDH2 PROTEIN, HUMAN; BIOLOGICAL MARKER; TRIACYLGLYCEROL;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; GENOTYPE; HEART INFARCTION; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; SMOKING; STABLE ANGINA PECTORIS; ADVERSE EFFECTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ENZYMOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; JAPAN; MIDDLE AGED; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

AGED; ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CASE-CONTROL STUDIES; CREATINE KINASE; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 84911396776     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.11.014     Document Type: Article

References (30)

1. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 2004, 43:1731-1737.
2. Barua R.S., Ambrose J.A. Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1460-1467.
3. Chen C.H., Budas G.R., Churchill E.N., Disatnik M.H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321:1493-1495.
4. Cui R., Kamatani Y., Takahashi A., Usami M., Hosono N., Kawaguchi T., Tsunoda T., Kamatani N., Kubo M., Nakamura Y., Matsuda K. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 2009, 137:1768-1775.
5. Dumitrescu L., Carty C.L., Franceschini N., Hindorff L.A., Cole S.A., Buzkova P., Schumacher F.R., Eaton C.B., Goodloe R.J., Duggan D.J., Haessler J., Cochran B., Henderson B.E., Cheng I., Johnson K.C., Carlson C.S., Love S.A., Brown-Gentry K., Nato A.Q., Quibrera M., Shohet R.V., Ambite J.L., Wilkens L.R., Le Marchand L., Haiman C.A., Buyske S., Kooperberg C., North K.E., Fornage M., Crawford D.C. No evidence of interaction between known lipid-associated genetic variants and smoking in the multi-ethnic PAGE population. Hum. Genet. 2013, 132:1427-1431.
6. Guo Y.J., Chen L., Bai Y.P., Li L., Sun J., Zhang G.G., Yang T.L., Xia J., Li Y.J., Chen X.P. The ALDH2 Glu504Lys polymorphism is associated with coronary artery disease in Han Chinese: relation with endothelial ADMA levels. Atherosclerosis 2010, 211:545-550.
7. Guo J.M., Liu A.J., Zang P., Dong W.Z., Ying L., Wang W., Xu P., Song X.R., Cai J., Zhang S.Q., Duan J.L., Mehta J.L., Su D.F. ALDH2 protects against stroke by clearing 4-HNE. Cell Res. 2013, 23:915-930.
8. Hu N., Han X., Lane E.K., Gao F., Zhang Y., Ren J. Cardiac-specific overexpression of metallothionein rescues against cigarette smoking exposure-induced myocardial contractile and mitochondrial damage. PLoS One 2013, 8:e57151.
9. Hu N., Zhang Y., Nair S., Culver B.W., Ren J. Contribution of ALDH2 polymorphism to alcoholism-associated hypertension. Recent Pat. Endocr. Metab. Immune Drug Discov. 2014, doi: EMI-EPUB-62942.
10. Kabagambe E.K., Ordovas J.M., Tsai M.Y., Borecki I.B., Hopkins P.N., Glasser S.P., Arnett D.K. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis 2009, 203:633-639.
11. Kasai T., Miyauchi K., Yanagisawa N., Kajimoto K., Kubota N., Ogita M., Tsuboi S., Amano A., Daida H. Mortality risk of triglyceride levels in patients with coronary artery disease. Heart 2013, 99:22-29.
12. Kato N., Takeuchi F., Tabara Y., Kelly T.N., Go M.J., Sim X., Tay W.T., Chen C.H., Zhang Y., Yamamoto K., Katsuya T., Yokota M., Kim Y.J., Ong R.T., Nabika T., Gu D., Chang L.C., Kokubo Y., Huang W., Ohnaka K., Yamori Y., Nakashima E., Jaquish C.E., Lee J.Y., Seielstad M., Isono M., Hixson J.E., Chen Y.T., Miki T., Zhou X., Sugiyama T., Jeon J.P., Liu J.J., Takayanagi R., Kim S.S., Aung T., Sung Y.J., Zhang X., Wong T.Y., Han B.G., Kobayashi S., Ogihara T., Zhu D., Iwai N., Wu J.Y., Teo Y.Y., Tai E.S., Cho Y.S., He J. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat. Genet. 2011, 43:531-538.
13. Lee J.Y., Jung G.Y., Heo H.J., Yun M.R., Park J.Y., Bae S.S., Hong K.W., Lee W.S., Kim C.D. 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol. Lett. 2006, 166:212-221.
14. Li Y., Zhang D., Jin W., Shao C., Yan P., Xu C., Sheng H., Liu Y., Yu J., Xie Y., Zhao Y., Lu D., Nebert D.W., Harrison D.C., Huang W., Jin L. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J. Clin. Invest. 2006, 116:506-511.
15. Lu X., Wang L., Lin X., Huang J., Charles Gu C., He M., Shen H., He J., Zhu J., Li H., Hixson J.E., Wu T., Dai J., Lu L., Shen C., Chen S., He L., Mo Z., Hao Y., Mo X., Yang X., Li J., Cao J., Chen J., Fan Z., Li Y., Zhao L., Li H., Lu F., Yao C., Yu L., Xu L., Mu J., Wu X., Deng Y., Hu D., Zhang W., Ji X., Guo D., Guo Z., Zhou Z., Yang Z., Wang R., Yang J., Zhou X., Yan W., Sun N., Gao P., Gu D. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum. Mol. Genet. 2014, 10.1093/hmg/ddu478.
16. Ma H., Guo R., Yu L., Zhang Y., Ren J. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur. Heart J. 2011, 32:1025-1038.
17. Mizuno Y., Morita S., Harada E., Shono M., Morikawa Y., Murohara T., Yasue H. Alcohol flushing and positive ethanol patch test in patients with coronary spastic angina: possible role of aldehyde dehydrogenase 2 polymorphisms. Intern. Med. 2013, 52:2593-2598.
18. Morita K., Oniki K., Miyazaki H., Saruwatari J., Ogata Y., Mizobe M., Yamamuro M., Hokimoto S., Ogawa H., Nakagawa K. Aldehyde dehydrogenase 2 as a potential protective factor for renal insufficiency in Japanese subjects with heart failure: a pilot study. J. Hum. Hypertens. 2014, 28:279-281.
19. Nakagawa T., Kajiwara A., Saruwatari J., Hamamoto A., Kaku W., Oniki K., Mihara S., Ogata Y., Nakagawa K. The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption. Pharmacogenet. Genomics 2013, 23:34-37.
20. O'Brien P.J., Siraki A.G., Shangari N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 2005, 35:609-662.
21. Okamura T., Kokubo Y., Watanabe M., Higashiyama A., Ono Y., Miyamoto Y., Yoshimasa Y., Okayama A. Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study. Atherosclerosis 2010, 209:290-294.
22. Park J.Y., Matsuo K., Suzuki T., Ito H., Hosono S., Kawase T., Watanabe M., Oze I., Hida T., Yatabe Y., Mitsudomi T., Takezaki T., Tajima K., Tanaka H. Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population. Carcinogenesis 2010, 31:660-665.
23. Selley M.L., Bartlett M.R., Czeti A.L., Ardlie N.G. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron. Atherosclerosis 1998, 140:105-112.
24. Stolle K., Berges A., Lietz M., Lebrun S., Wallerath T. Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice. Toxicol. Lett. 2010, 199:403-409.
25. Takagi S., Iwai N., Yamauchi R., Kojima S., Yasuno S., Baba T., Terashima M., Tsutsumi Y., Suzuki S., Morii I., Hanai S., Ono K., Baba S., Tomoike H., Kawamura A., Miyazaki S., Nonogi H., Goto Y. Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens. Res. 2002, 25:677-681.
26. Takeuchi F., Yokota M., Yamamoto K., Nakashima E., Katsuya T., Asano H., Isono M., Nabika T., Sugiyama T., Fujioka A., Awata N., Ohnaka K., Nakatochi M., Kitajima H., Rakugi H., Nakamura J., Ohkubo T., Imai Y., Shimamoto K., Yamori Y., Yamaguchi S., Kobayashi S., Takayanagi R., Ogihara T., Kato N. Genome-wide association study of coronary artery disease in the Japanese. Eur. J. Hum. Genet. 2012, 20:333-340.
27. Xu F., Chen Y.G., Xue L., Li R.J., Zhang H., Bian Y., Zhang C., Lv R.J., Feng J.B., Zhang Y. Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome. J. Cell. Mol. Med. 2011, 15:1955-1962.
28. Yagi H., Komukai K., Hashimoto K., Kawai M., Ogawa T., Anzawa R., Minai K., Nagoshi T., Ogawa K., Taniguchi I., Yoshimura M. Difference in risk factors between acute coronary syndrome and stable angina pectoris in the Japanese: smoking as a crucial risk factor of acute coronary syndrome. J. Cardiol. 2010, 55:345-353.
29. Yasue H., Nakagawa H., Itoh T., Harada E., Mizuno Y. Coronary artery spasm-clinical features, diagnosis, pathogenesis, and treatment. J. Cardiol. 2008, 51:2-17.
30. Zhang Y., Ren J. ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications. Pharmacol. Ther. 2011, 132:86-95.